BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17646546)

  • 1. Gfi1 ubiquitination and proteasomal degradation is inhibited by the ubiquitin ligase Triad1.
    Marteijn JA; van der Meer LT; van Emst L; van Reijmersdal S; Wissink W; de Witte T; Jansen JH; Van der Reijden BA
    Blood; 2007 Nov; 110(9):3128-35. PubMed ID: 17646546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin ligase Triad1 inhibits myelopoiesis through UbcH7 and Ubc13 interacting domains.
    Marteijn JA; van der Meer LT; Smit JJ; Noordermeer SM; Wissink W; Jansen P; Swarts HG; Hibbert RG; de Witte T; Sixma TK; Jansen JH; van der Reijden BA
    Leukemia; 2009 Aug; 23(8):1480-9. PubMed ID: 19340006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diminished proteasomal degradation results in accumulation of Gfi1 protein in monocytes.
    Marteijn JA; van der Meer LT; Van Emst L; de Witte T; Jansen JH; van der Reijden BA
    Blood; 2007 Jan; 109(1):100-8. PubMed ID: 16888099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells.
    Marteijn JA; van Emst L; Erpelinck-Verschueren CA; Nikoloski G; Menke A; de Witte T; Löwenberg B; Jansen JH; van der Reijden BA
    Blood; 2005 Dec; 106(13):4114-23. PubMed ID: 16118314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRIAD1 is negatively regulated by the MDM2 E3 ligase.
    Bae S; Jung JH; An IS; Kim OY; Lee MJ; Lee JH; Park IC; Lee SJ; An S
    Oncol Rep; 2012 Nov; 28(5):1924-8. PubMed ID: 22940738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E3 ubiquitin ligase SMAD ubiquitination regulatory factor 2 negatively regulates Krüppel-like factor 5 protein.
    Du JX; Hagos EG; Nandan MO; Bialkowska AB; Yu B; Yang VW
    J Biol Chem; 2011 Nov; 286(46):40354-64. PubMed ID: 21953463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug target.
    Alchanati I; Teicher C; Cohen G; Shemesh V; Barr HM; Nakache P; Ben-Avraham D; Idelevich A; Angel I; Livnah N; Tuvia S; Reiss Y; Taglicht D; Erez O
    PLoS One; 2009 Dec; 4(12):e8104. PubMed ID: 19956605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.
    Oh Y; Chung KC
    J Biol Chem; 2013 Mar; 288(13):9102-11. PubMed ID: 23404503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination.
    Hosoda M; Ozaki T; Miyazaki K; Hayashi S; Furuya K; Watanabe K; Nakagawa T; Hanamoto T; Todo S; Nakagawara A
    Oncogene; 2005 Nov; 24(48):7156-69. PubMed ID: 16170377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin ligase Triad1 promotes neurite outgrowth by inhibiting MDM2-mediated ubiquitination of the neuroprotective factor pleiotrophin.
    Wu C; Xu G; Bao G; Gao H; Chen J; Zhang J; Chen C; Hong H; Xue P; Jiang J; Liu Y; Huang J; Sun Y; Fu J; Li Y; Cui Z
    J Biol Chem; 2022 Oct; 298(10):102443. PubMed ID: 36055408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin ligase HECW1 targets thyroid transcription factor 1 (TTF1/NKX2.1) for its degradation in the ubiquitin-proteasome system.
    Liu J; Dong S; Li L; Wang H; Zhao J; Zhao Y
    Cell Signal; 2019 Jun; 58():91-98. PubMed ID: 30849519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl down-regulates interleukin-12 expression.
    Xiong H; Li H; Kong HJ; Chen Y; Zhao J; Xiong S; Huang B; Gu H; Mayer L; Ozato K; Unkeless JC
    J Biol Chem; 2005 Jun; 280(25):23531-9. PubMed ID: 15837792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E3 ubiquitin ligase thyroid hormone receptor-interacting protein 12 targets pancreas transcription factor 1a for proteasomal degradation.
    Hanoun N; Fritsch S; Gayet O; Gigoux V; Cordelier P; Dusetti N; Torrisani J; Dufresne M
    J Biol Chem; 2014 Dec; 289(51):35593-604. PubMed ID: 25355311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.
    Zhang HT; Zeng LF; He QY; Tao WA; Zha ZG; Hu CD
    Biochim Biophys Acta; 2016 Feb; 1863(2):335-46. PubMed ID: 26658161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SUMOylation Regulates Growth Factor Independence 1 in Transcriptional Control and Hematopoiesis.
    Andrade D; Velinder M; Singer J; Maese L; Bareyan D; Nguyen H; Chandrasekharan MB; Lucente H; McClellan D; Jones D; Sharma S; Liu F; Engel ME
    Mol Cell Biol; 2016 May; 36(10):1438-50. PubMed ID: 26951200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZSCAN4 is negatively regulated by the ubiquitin-proteasome system and the E3 ubiquitin ligase RNF20.
    Portney BA; Khatri R; Meltzer WA; Mariano JM; Zalzman M
    Biochem Biophys Res Commun; 2018 Mar; 498(1):72-78. PubMed ID: 29477841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bag1 directly routes immature BCR-ABL for proteasomal degradation.
    Tsukahara F; Maru Y
    Blood; 2010 Nov; 116(18):3582-92. PubMed ID: 20675402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polycomb protein Ring1B generates self atypical mixed ubiquitin chains required for its in vitro histone H2A ligase activity.
    Ben-Saadon R; Zaaroor D; Ziv T; Ciechanover A
    Mol Cell; 2006 Dec; 24(5):701-711. PubMed ID: 17157253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.
    Xia T; Dimitropoulou C; Zeng J; Antonova GN; Snead C; Venema RC; Fulton D; Qian S; Patterson C; Papapetropoulos A; Catravas JD
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3080-7. PubMed ID: 17873020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.